The more mutations the tumor accumulates, the higher likelihood of production and subsequent presentation of neoantigens on major MHC molecules causing a higher tendency of tumor cell cytotoxicity after inhibition of checkpoint signals (56, 57). Here, HLA-C is linked to neoplasm.